MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 33 filers reported holding MYOVANT SCIENCES LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,068,000 | -45.9% | 6,166,875 | -5.8% | 1.91% | -39.9% |
| Q2 2019 | $59,238,000 | -30.0% | 6,545,642 | +84.7% | 3.18% | -12.8% |
| Q1 2019 | $84,601,000 | +38.9% | 3,544,227 | -4.5% | 3.65% | +2.9% |
| Q4 2018 | $60,907,000 | -33.5% | 3,711,549 | +7.5% | 3.54% | -27.7% |
| Q3 2018 | $91,647,000 | +41.6% | 3,451,859 | +22.0% | 4.90% | +16.6% |
| Q2 2018 | $64,733,000 | +7.5% | 2,830,455 | 0.0% | 4.20% | -8.9% |
| Q1 2018 | $60,204,000 | +68.3% | 2,830,455 | 0.0% | 4.61% | +54.1% |
| Q4 2017 | $35,777,000 | -18.3% | 2,830,455 | 0.0% | 2.99% | -24.3% |
| Q3 2017 | $43,787,000 | +33.3% | 2,830,455 | +0.8% | 3.96% | +5.0% |
| Q2 2017 | $32,848,000 | +19.1% | 2,807,550 | +19.6% | 3.77% | +11.4% |
| Q1 2017 | $27,570,000 | +47.7% | 2,348,422 | +56.6% | 3.38% | +27.9% |
| Q4 2016 | $18,660,000 | – | 1,500,000 | – | 2.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |